Success Stories: In Just 1 Month and 14 Days, a Venezuelan Postdoctoral Fellow in Biotechnologies Gets NIW Approval, Thanks to Premium Processing Upgrade and Our Team
Client’s Testimonial:
“Thank you! It has been great working with you.”
On February 22nd, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Biotechnologies (Approval Notice).
General Field: Biotechnologies
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: Venezuela
State of Residence at the Time of Filing: Maryland
Approval Notice Date: February 22nd, 2023
Processing Time: 1 month, 14 days (Premium Processing Requested)
Case Summary:
“[The client’s] work centered on creating a new way to screen for patient receptiveness to immunotherapy is a major achievement. Immunotherapy avoids many of the side effects of chemotherapy, and his work underpins new efforts to identify patients most likely to benefit from immunotherapy in order to reduce the use of chemotherapy. Given his accomplishments, I support [the client’s] continued work in the United States”
This statement was made for a postdoctoral research fellow in biotechnologies by another expert who understood the value of his work for the U.S. This Venezuelan expert wanted to continue testing new drugs using spectral flow cytometry, extracellular vesicle isolation, and Western blotting and determine molecular mechanisms of various health conditions like inflammatory cardiovascular diseases in order to develop novel treatments. So when he wanted to apply for a National Interest Waiver visa under the EB2 category, he came to NAILG for our assistance.
As is customary, our team worked on his case and used the following information to write an impressive petition for him:
- We said that his research advancing his proposed endeavor is of great importance because it directly combats cardiovascular diseases, one of the leading causes of death worldwide.
- His proposed endeavor also has broad implications for the United States where heart disease is the leading cause of death for men, women, and most racial and ethnic groups, claiming roughly 700,000 lives every year and costing the U.S. over $300 billion annually.
- Due to its clear national importance, his research has in fact been supported with funding from the National Institutes of Health.
- Additionally, he has completed at least 2 reviews to date and his research has resulted in 11 peer-reviewed journal articles (5 of them first-authored).
- Not only this, but his research has also gone on to influence his peers. That is, his publications have been cited a total of 179 times according to Google Scholar.
- To corroborate this information we added 4 letters of support written by other experts in the area.
- Finally, we said that he has pursued research directly related to his proposed endeavor of testing new drugs using spectral flow cytometry, extracellular vesicle isolation, and Western blotting for 8 years.